We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Shanghai Laboratory to Develop Molecular Solutions for Diagnostics

By HospiMedica staff writers
Posted on 04 Sep 2007
A laboratory is to be established in Shanghai whose ultimate aim is to create new solutions for the early diagnosis of disease and for monitoring the effectiveness of subsequent treatment.

In particular, the laboratory investigations will be aimed at biomarker discovery and test development for next-generation in vitro diagnostic testing. More...
Important application examples of next-generation in vitro diagnostics will include near-patient health monitoring at virtually every stage of clinical care, from routine screening right through to diagnosis, treatment, and disease management.

Royal Philips Electronics (Einhoven, The Netherlands) and the Institute of Health Sciences (IHS; Shanghai, China) announced an agreement to establish the laboratory within the IHS in Shanghai, China. The IHS is part of the Shanghai Institutes for Biological Sciences (SIBS; China) and is also affiliated to the Shanghai Jiao Tong University School of Medicine (Shanghai, China). The laboratory will conduct advanced investigations in the field of molecular medicine. As part of the collaboration, Philips intends to locate a team of its own scientists at the laboratory.

"This collaboration will give us access to Philips' global research organization, especially the European laboratories, and should serve as a good example for further European collaborations,” says Prof. Rongxing Gan, vice president of SIBS. "The combination of our expertise in translational biomedical research and Philips' expertise in advanced medical instrumentation will definitely accelerate the development of new healthcare solutions for the Chinese people as well as people around the world.”

Philips Research has been building the necessary competencies in molecular biology, bioinformatics, and molecular diagnostics as priorities in its diagnostic imaging and patient monitoring expertise. It has already established a dedicated biomolecular life-sciences facility on the High Tech Campus in Eindhoven, the Netherlands.

"This agreement to set up a joint research laboratory with the IHS in China is a prime example of the open innovation approach that Philips is taking in order to bring the many benefits of molecular medicine into patient care,” says Rick Harwig, CTO of Royal Philips Electronics. "As an international company with an ambition to provide healthcare solutions that are tailored to local needs, we are delighted to be partnering with a Chinese institute that within the space of a few years has become renowned for its life sciences research.”


Related Links:
Royal Philips Electronics
Institute of Health Sciences
Shanghai Institutes for Biological Sciences

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.